ArticleInvestigative and clinical urology2022
Changes in prostate-specific antigen kinetics during androgen-deprivation therapy as a predictor of response to abiraterone in chemonaïve patients with metastatic castration-resistant prostate cancer.
Chung-Lin Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.